Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Mechanism of Smoldering Disease

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Disease Progression Monitoring

EoETaly Guidelines Part-2

Smoldering Disease Burden

Smoldering Disease Detection

BTK Enzyme

Disease Overview

EoETaly Guidelines Part-1

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage